Assignee
INTREXON CORP
US·69 granted patents·43 pending applications·808 citations·filing 2002–2020
Top patents by PatentIndex Score
112 records- 0198US9677055B2Modified forms of Pseudomonas exotoxin AINTREXON CORP·Filed 2016·Granted Jun 13, 2017·23 cites·23 claims
- 0297US7935510B2Mutant receptors and their use in a nuclear receptor-based inducible gene expression systemINTREXON CORP·Filed 2005·Granted May 3, 2011·51 cites·32 claims
- 0397US7807417B2Ecdysone receptor-based inducible gene expression systemINTREXON CORP·Filed 2007·Granted Oct 5, 2010·53 cites·28 claims
- 0497US7776587B2Ecdysone receptor-based inducible gene expression systemINTREXON CORP·Filed 2007·Granted Aug 17, 2010·54 cites·22 claims
- 0597US7601508B2Whitefly ecdysone receptor polypeptide and methodsINTREXON CORP·Filed 2007·Granted Oct 13, 2009·30 cites·6 claims
- 0696US7829676B2Whitefly ecdysone receptor antibodyINTREXON CORP·Filed 2009·Granted Nov 9, 2010·28 cites·2 claims
- 0796US7531326B2Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression systemINTREXON CORP·Filed 2002·Granted May 12, 2009·72 cites·10 claims
- 0895US8030067B2Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereofINTREXON CORP·Filed 2010·Granted Oct 4, 2011·23 cites·30 claims
- 0995US8021878B2Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereofINTREXON CORP·Filed 2007·Granted Sep 20, 2011·30 cites·34 claims
- 1095US7456315B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2004·Granted Nov 25, 2008·67 cites·4 claims
- 1194US7897394B2Endoplasmic reticulum localization signalsINTREXON CORP·Filed 2007·Granted Mar 1, 2011·14 cites·22 claims
- 1294US7563928B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2007·Granted Jul 21, 2009·23 cites·2 claims
- 1394US7304161B2Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complexINTREXON CORP·Filed 2004·Granted Dec 4, 2007·38 cites·5 claims
- 1494US7071295B2Signal for targeting molecules to the sarco(endo)plasmic reticulumINTREXON CORP·Filed 2003·Granted Jul 4, 2006·44 cites·20 claims
- 1593US9399783B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2016·Granted Jul 26, 2016·14 cites·10 claims
- 1693US7943732B2AKT ligands and polynucleotides encoding AKT ligandsINTREXON CORP·Filed 2007·Granted May 17, 2011·16 cites·12 claims
- 1793US7705122B2mTOR ligands and polynucleotides encoding mTOR ligandsINTREXON CORP·Filed 2007·Granted Apr 27, 2010·9 cites·19 claims
- 1893US7563879B2Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereofINTREXON CORP·Filed 2002·Granted Jul 21, 2009·39 cites·17 claims
- 1992US9745603B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2016·Granted Aug 29, 2017·9 cites·9 claims
- 2092US9512148B2Boron-containing diacylhydrazinesINTREXON CORP·Filed 2015·Granted Dec 6, 2016·15 cites·22 claims
- 2192US7851220B2Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complexINTREXON CORP·Filed 2007·Granted Dec 14, 2010·14 cites·6 claims
- 2291US9267158B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2014·Granted Feb 23, 2016·13 cites·5 claims
- 2391US7919269B2Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereofINTREXON CORP·Filed 2002·Granted Apr 5, 2011·29 cites·12 claims
- 2490US9447387B2Modified forms of pseudomonas exotoxin AINTREXON CORP·Filed 2015·Granted Sep 20, 2016·3 cites·22 claims
- 2589US10876137B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2017·Granted Dec 29, 2020·4 cites·10 claims
- 2689US9127024B2Boron-containing diacylhydrazinesINTREXON CORP·Filed 2014·Granted Sep 8, 2015·12 cites·38 claims
- 2788US11771718B2Polypeptide compositions comprising spacersINTREXON CORP·Filed 2018·Granted Oct 3, 2023·3 cites·34 claims
- 2887US10081817B2Site-specific serine recombinases and methods of their useINTREXON CORP·Filed 2016·Granted Sep 25, 2018·7 cites·28 claims
- 2987US9371517B2Modified forms of Pseudomonas exotoxin AINTREXON CORP·Filed 2014·Granted Jun 21, 2016·3 cites·23 claims
- 3086US11821019B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2020·Granted Nov 21, 2023·2 cites·19 claims
- 3186US9272986B2Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complexINTREXON CORP·Filed 2014·Granted Mar 1, 2016·7 cites·19 claims
- 3286US7785871B2DNA cloning vector plasmids and methods for their useINTREXON CORP·Filed 2003·Granted Aug 31, 2010·12 cites·12 claims
- 3384US7304162B2Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2004·Granted Dec 4, 2007·17 cites·5 claims
- 3483US9096680B2mTOR ligands and polynucleotides encoding mTOR ligandsINTREXON CORP·Filed 2014·Granted Aug 4, 2015·2 cites·20 claims
- 3582US10046049B2Engineered cells expressing multiple immunomodulators and uses thereofINTREXON CORP·Filed 2016·Granted Aug 14, 2018·3 cites·17 claims
- 3681US9724430B2Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereofINTREXON CORP·Filed 2015·Granted Aug 8, 2017·3 cites·4 claims
- 3780US7375093B2Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2003·Granted May 20, 2008·8 cites·12 claims
- 3879US9359289B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2013·Granted Jun 7, 2016·2 cites·9 claims
- 3978US10464951B2Boron-containing diacylhydrazinesINTREXON CORP·Filed 2016·Granted Nov 5, 2019·2 cites·18 claims
- 4078US9115361B2Methods for dynamic vector assembly of DNA cloning vector plasmidsINTREXON CORP·Filed 2014·Granted Aug 25, 2015·1 cites·5 claims
- 4177US10584351B2Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereofINTREXON CORP·Filed 2017·Granted Mar 10, 2020·2 cites·30 claims
- 4277US9675642B2Engineered dendritic cells and uses for the treatment of cancerINTREXON CORP·Filed 2013·Granted Jun 13, 2017·3 cites·7 claims
- 4376US9181314B2mTOR ligands and polynucleotides encoding mTOR ligandsINTREXON CORP·Filed 2015·Granted Nov 10, 2015·1 cites·26 claims
- 4475US9598355B2Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2014·Granted Mar 21, 2017·1 cites·21 claims
- 4573US9169306B2Endoplasmic reticulum localization signalsINTREXON CORP·Filed 2014·Granted Oct 27, 2015·1 cites·5 claims
- 4673US2020270225A1Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor ComplexINTREXON CORP·Filed 2020·Application pending·0 cites
- 4771US11198877B2Molecular switchesINTREXON CORP·Filed 2018·Granted Dec 14, 2021·0 cites·17 claims
- 4871US9604913B2Crystalline diacylhydrazine and the use thereofINTREXON CORP·Filed 2014·Granted Mar 28, 2017·1 cites·8 claims
- 4970US10633361B2Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2017·Granted Apr 28, 2020·0 cites·15 claims
- 5069US9493525B2AKT ligands and polynucleotides encoding AKT ligandsINTREXON CORP·Filed 2014·Granted Nov 15, 2016·0 cites·20 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →